A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer
- 1 May 1991
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 27 (5), 571-575
- https://doi.org/10.1016/0277-5379(91)90220-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose RegimenJNCI Journal of the National Cancer Institute, 1989
- Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- A New International Staging System for Lung CancerChest, 1986
- New agents in non-small cell lung cancerCancer Treatment Reviews, 1984
- Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized studyEuropean Journal of Cancer and Clinical Oncology, 1984
- Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the futureCancer Treatment Reviews, 1983
- Planning the size and duration of a clinical trial studying the time to some critical eventJournal of Chronic Diseases, 1974
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataPublished by JSTOR ,1973
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958